
Earlybird nears close of healthtech fund
Earlybird Venture Capital is expected to close its €100m Europe-focused healthtech fund this year.
The vehicle is understood to have been encouraged by LPs wishing to separate healthcare and technology investments from the VC's wider portfolio.
Headed up by partner and co-founder of Earlybird, Rolf Mathies, the healthtech team includes partner Thom Rasche, partner John Yianni, and Lionel Camot, named as liaison partner at Earlybird and current investment partner at Bay City Capital.
Earlybird also manages the CEE-focused Earlybird Digital East Fund, which held a first close on $110m in January 2014. The fund made its maiden commitments in May, backing Tjobs and Metrekare, and is expected to hold a final close in the coming months.
In August 2013, the VC also closed its fourth vehicle, Earlybird 2012 Fund, on €150m. In keeping with Earlybird's strategy, the fund targets early-stage European tech opportunities, though also commits to later-stage rounds.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater